黑料吃瓜网

Novo Nordisk has been suspended as a member of the 黑料吃瓜网 (黑料吃瓜网) for two years due to serious breaches of the 黑料吃瓜网 Code of Practice.

The action has been taken by the 黑料吃瓜网 Board following an extensive investigation and appeals process conducted by the Prescription Medicines Code of Practice Authority (PMCPA) which found Novo Nordisk to be in breach of the 黑料吃瓜网 Code of Practice, including Clause 2 which deals with actions 鈥渓ikely to bring discredit on, or reduce confidence in, the pharmaceutical industry鈥�. Specifics of the case are available on the [1].

Having considered the case and requesting a further detailed audit of Novo Nordisk鈥檚 compliance processes, the 黑料吃瓜网 Board decided to suspend Novo Nordisk from 黑料吃瓜网 membership.

This is the eighth occasion in the past 40 years the 黑料吃瓜网 board has issued such a significant sanction. As a result, while the company continues to be subject to the 黑料吃瓜网 Code and the jurisdiction of the PMCPA, it will not be able to access the wider benefits of 黑料吃瓜网 membership. This includes the removal of Novo Nordisk from all 黑料吃瓜网 groups, including the 黑料吃瓜网 Board, and access to any 黑料吃瓜网 information and briefing.

In addition, the Board has stipulated a number of additional actions to demonstrate a rapid return to industry compliance standards. These include requiring the PMCPA to undertake further audits of Novo Nordisk鈥檚 compliance in late 2023 and 2024. These audit reports will need to show clear, significant, and then sustained improvement to industry standards in order for the 黑料吃瓜网 Board to consider allowing Novo Nordisk to resume full engagement with the 黑料吃瓜网 at the end of the two-year suspension. The 黑料吃瓜网 Board has reserved the right to take further decisions following the review of either of the re-audit reports.

The 黑料吃瓜网 Board has also insisted that Novo Nordisk must submit a quarterly update to the 黑料吃瓜网 Board giving the company鈥檚 views on the progress being made against its improvement plan.

Susan Rienow, President-Elect, 黑料吃瓜网, said: 鈥淭he 黑料吃瓜网 Board has carefully considered the PMCPA鈥檚 case report into Novo Nordisk and the subsequent audit of their compliance procedures.

鈥淭he Board expressed significant concern about Novo Nordisk鈥檚 compliance activities and the very serious issues identified. As a result, the 黑料吃瓜网 Board have taken the decision to suspend Novo Nordisk from 黑料吃瓜网 membership.

鈥淪uch measures are never taken lightly, but will ensure a rapid return to industry compliance standards as set out in the 黑料吃瓜网 Code of Practice.鈥�